Current Biotechnology ›› 2022, Vol. 12 ›› Issue (2): 229-235.DOI: 10.19586/j.2095-2341.2021.0156
• Reviews • Previous Articles Next Articles
Shuxiang LI(
), Liping AN, Dejuan LIANG, Kaixuan WANG, Jianguo ZHAO(
)
Received:2021-09-22
Accepted:2021-11-12
Online:2022-03-25
Published:2022-03-28
Contact:
Jianguo ZHAO
通讯作者:
赵建国
作者简介:李书翔 E-mail:2060709772@qq.com;
基金资助:CLC Number:
Shuxiang LI, Liping AN, Dejuan LIANG, Kaixuan WANG, Jianguo ZHAO. Research Progress on the Treatment of Prion Disease[J]. Current Biotechnology, 2022, 12(2): 229-235.
李书翔, 安丽萍, 梁德娟, 王凯旋, 赵建国. 朊病毒病治疗方法的研究进展[J]. 生物技术进展, 2022, 12(2): 229-235.
| 1 | 张珠明,汪仁莉,赵德明.朊病毒病治疗的研究进展[J].中国兽医杂志,2012,48(3):58-60. |
| 2 | 秦笙,彭健愉,柏彩英,等.黄芩素对朊蛋白PrP106-126片段引起的神经毒性保护作用研究[J].中国医药导报,2019,16(34):7-10, 181. |
| 3 | 杨微,陈志宝,陈操,等.桦褐孔菌乙醇粗提物对朊病毒复制的抑制作用[J].现代食品科技,2021,37(7): 8-13, 7. |
| 4 | CHAO H, CAO C, JIA C, et al.. The low levels of nerve growth factor and its upstream regulatory kinases in prion infection is reversed by resveratrol[J]. Neurosci. Res., 2021, 162: 52-62.. |
| 5 | 周冬花.芷类对朊病毒体外复制的影响及作用机制研究[D].北京:中国疾病预防控制中心,2019. |
| 6 | 李辉,卜祥龙,窦爽,等.淫羊藿提取物对酵母朊病毒[PSI+]治愈的影响[J].微生物学杂志, 2013,33(5):42-45. |
| 7 | 张艳,刘宴村,宋有涛.钩藤提取物对感染朊病毒酵母模型的治疗作用[J].动物医学进展,2015,36(9):84-87. |
| 8 | SOSHI K. Targeting the endoplasmic reticulum in prion disease treatment: breakthroughs and challenges[J]. Res. Rep. Biochem., 2015, 2015(5): 31-38. |
| 9 | MALLUCCI G, DICKINSON A, LINEHAN J, et al.. Depleting neuronal Prp in prion infection prevents disease and reverses spongiosis[J]. Science, 2003, 302(5646): 871-874. |
| 10 | HALLIDAY M, RADFORD H, SEKINE Y, et al.. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity[J/OL]. Cell Death Dis., 2015, 6(3): e1672[2020-11-12]. . |
| 11 | HALLIDAY M, HELOIS R, ZENTS K A M, et al.. Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice[J]. Brain, 2017, 140(6): 1768-1783. |
| 12 | DAS I, KRZYZOSIAK A, SCHNEIDER K, et al.. Preventing proteostasis diseases by selective inhibitionof a phosphatase regulatory subunit[J]. Science, 2015, 348(6231): 239-242. |
| 13 | 许尹.自噬系统在朊病毒感染过程中的变化规律及机制研究[D].北京:中国疾病预防控制中心,2013. |
| 14 | CORTES C J, QIN K, COOK J, et al.. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease[J]. J. Neurosci., 2012, 32(36): 12396-12405. |
| 15 | GRZMIL M, HEMMINGS B A. Overcoming resistance to rapalogs in gliomas by combinatory therapies[J]. Biochim. Biophys. Acta, 2013, 1834(7): 1371-1380. |
| 16 | MI W, YE Q, LIU S, et al.. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis[J]. Oncotarget, 2015, 6(16): 13962-13977. |
| 17 | 杨威.PRAS40缓解神经毒性多肽诱导神经元凋亡机制的研究[D].北京:中国农业大学,2017. |
| 18 | KARAPETYAN Y E, SFERRAZZA G F, ZHOU M, et al.. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents[J]. Proc. Natl. Acad. Sci. USA, 2013, 110(17):7044-7049. |
| 19 | YUN S W, ERTMER A, FLECHSIG E, et al.. The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery[J]. J. Neurovirol., 2007, 13(4): 328-337. |
| 20 | HEISEKE A, AGUIB Y, RIEMER C, et al.. Lithium induces clearance of protease resistat prion protein in prion-infected cells by induction of autophagy[J]. J. Neurochem., 2009, 109(1): 25-34. |
| 21 | 宋志琦.REST在朊病毒疾病模型中神经保护作用机制的研究[D].北京:中国农业大学,2018. |
| 22 | 张腾龙,陈志宝,鞠传静,等.朊病毒病治疗的研究进展[J].中国人兽共患病学报,2015,31(1):54-59. |
| 23 | 阿达莱提·买买提明,武月章,谢姆斯耶·吾拉音,等.线粒体靶向抗氧化剂Mitoquinone和积雪草酸对朊病毒感染的神经细胞的治疗作用研究[J].病毒学报, 2019, 35(2): 247-254. |
| 24 | FARIS R, MOORE R A, WARD A, et al.. Mitochondrial respiration is impaired during late stage hamster prion infection[J/OL]. J. Virol., 2017, 91(18): e00524-17[2020-12-01]. . |
| 25 | 杨晓东,陈利娜,董小平,等.线粒体功能异常与朊病毒病的关系[J].中国病毒病杂志, 2015(4): 313-316. |
| 26 | ANSOLEAGA B, GARCIA-ESPARCIA P, LLORENS F, et al.. Altered mitochondria, protein synthesis machinery, and purine metabolism are molecular contributors to the pathogenesis of Creutzfeldt-Jakob disease[J]. J. Neuropathol. Exp. Neurol., 2016, 75(8): 755-769. |
| 27 | LEE D W, SOHN H O, LIM H B, et al.. Alteration of free radical metabolism in the brain of mice infected with scrapie agent[J]. Free Radic. Res., 1999, 30(6): 499-507. |
| 28 | PARK Y G, JEONG J K, MOON M H, et al.. Insulin-like growth factor-1 protects against prion peptide-induced cell death in neuronal cells via inhibition of Bax translocation[J]. Int. J. Mol. Med., 2012, 30(5): 1069-1074. |
| 29 | 高利萍.E200K突变朊病毒病的疾病特征及朊病毒感染过程中线粒体自噬的研究[D].北京:中国疾病预防控制中心,2020. |
| 30 | 李超斯.DLP1调控线粒体动力学失衡在朊病毒疾病模型中的作用机制[D].北京:中国农业大学,2018. |
| 31 | 程胖.利用RNAi抑制牛胎儿成纤维细胞中prnp基因的表达[D].咸阳:西北农林科技大学, 2010. |
| 32 | PFLANZ H, VANA K, MITTEREGGER G, et al.. Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice[J]. J. Gen. Virol., 2009, 90(Pt 1): 269-74. |
| 33 | RAYMOND G J, ZHAO H T, RACE B, et al.. Antisense oligonucleotides extend survival of prion-infected mice[J/OL]. JCI Insight, 2019, 5(16): e131175[2021-02-05]. . |
| 34 | MINIKEL E V, ZHAO H T, LE J, et al.. Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints[J]. Nucl. Acids Res., 2020, 48(19): 10615-10631. |
| 35 | WUERTZER C A, SULLIVAN M A, QIU X, et al.. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset[J]. Mol. Ther., 2008, 16(3): 481-486. |
| 36 | JONES D R, TAYLOR W R, BATE C, et al.. A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines[J/OL]. PLoS ONE, 2010, 5(3): e9804[2020-12-11]. . |
| 37 | MONTRASIO F, FRIGG R, GLATZEL M, et al.. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells[J]. Science, 2000, 288(5469): 1257-1259. |
| 38 | FERNANDEZ-BORGES N, BRUN A, WHITTON J L, et al.. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge[J]. J. Virol., 2006, 80(20): 9970-9976. |
| 39 | BACHY V, BALLERINI C, GOURDAIN P, et al.. Mousevaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie[J]. Gen. Virol., 2010, 91(Pt 3): 809-820. |
| 40 | ABDELAZIZ D H, THAPA S, ABDULRAHMAN B, et al. Immunization of cervidizedtransgenic mice with multimeric deer prion protein induces self-antibodies that antagonize chronic wasting disease infectivity in vitro[J/OL]. Sci. Rep., 2017, 7(1): 10538[2021-03-10]. . |
| 41 | ABDELAZIZ D H, THAPA S, BRANDON J, et al.. Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance andprotects mice against chronic wasting disease[J]. Biol. Chem., 2018, 293(51): 19812-19822. |
| 42 | SOLFOROSI L, CRIADO J R, MCGAVERN D B, et al.. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo[J]. Science, 2004, 303(5663): 1514-1516. |
| 43 | WANG F, WANG X, ORRÚ C D, et al.. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity[J/OL]. PLoS Pathog., 2017, 13(7):e1006491[2021-04-10]. . |
| 44 | LI Q, WANG F, XIAO X, et al.. Structural attributes of mammalian prion infectivity: insights from studies with synthetic prions[J]. J. Biol. Chem., 2018, 293(48):18494-18503. |
| 45 | SKINNER P J, KIM H O, DAMANI B, et al.. Treatment of prion disease with heterologous prion proteins[J/OL]. PLoS ONE, 2015, 10(7): e0131993[2021-04-22]. . |
| 46 | 刘怡芳,吕杰.克雅病生物标本检测研究进展[J].职业与健康, 2020,36(5):697-700. |
| 47 | ERAÑA H, CHARCO J M, GONZÁLEZ-MIRANDA E, et al.. Detection of pathognomonic biomarker PrPSc and the contribution of cell free-amplification techniques to the diagnosis of prion diseases[J/OL]. Biomolecules, 2020, 10(3): 469[2021-04-30]. . |
| 48 | ASCARI L M, ROCHA S C, GONALVEs P B, et al.. Challenges and advances in antemortem diagnosis of human transmissible spongiform encephalopathies[J/OL]. Front. Bioeng. Biotechnol., 2020, 8: 585896[2021-04-30]. . |
| 49 | 秦川,张连峰.常见和新发传染病动物模型[M].北京:中国协和医科大学出版社,2012:178-179. |
| 50 | 王冬冬,杨利峰,赵德明,等.传染性海绵状脑病果蝇模型研究进展[J/OL].中国实验动物学报,2017:1-5[2021-10-30]. . |
| 51 | 马月,高利萍,肖康,等.核转录因子-κB(p65)在羊瘙痒因子139A感染小鼠脑组织中变化的研究[J].疾病监测, 2018,33(1):32-36. |
| 52 | 张仁庆. 朊病毒病中CaM信号通路变化特点的研究[D]. 大庆:黑龙江八一农垦大学,2017. |
| 53 | 孙静.经典Wnt通路在朊病毒病中抑制及其机制研究[D].北京:中国疾病预防控制中心,2016. |
| 54 | SHAH S Z A. FK506与米诺环素联合用药对朊病毒感染金黄地鼠治疗作用研究[D].北京:中国农业大学,2018. |
| [1] | Xiaoyu JIANG, Yi CHEN, Jingjing NI. Mechanism of miR-93 Regulating Immune-mediated Traumatic Brain Injury Through Activation of PI3K/AKT Pathway [J]. Current Biotechnology, 2025, 15(4): 711-719. |
| [2] | Xiaoya LIU, Shuomin ZHANG, Peng ZHENG, Rui MA, Chaojun ZHANG. Role and Mechanisms of DBNDD1 in Colorectal Cancer Development [J]. Current Biotechnology, 2025, 15(4): 726-734. |
| [3] | Bingyue QIU, Jiateng SHI, Jing JIN. Research Progress of siRNA Gene Therapy in Tendon Injury Repair [J]. Current Biotechnology, 2025, 15(3): 411-417. |
| [4] | Yuqin BIAN, Keran DONG, Junzi LU, Enming ZHONG, Wanying GU, Jingshu ZHAO, Hongshu SUI. Clinical Progress in Targeted Therapy and Immunotherapy in Breast Cancer [J]. Current Biotechnology, 2025, 15(2): 234-240. |
| [5] | Yiyang LI, Zhizheng ZHOU, Shufei WANG, Boya LIU, Yufei LIU, Xiaoyan LI, Hongshu SUI, Dongwei LIU. Application and Prospect of CRISPR/Cas9 Gene Editing Technology in Disease Treatment [J]. Current Biotechnology, 2025, 15(1): 35-42. |
| [6] | Hongkai WANG, Yujie WANG, Xiaohan ZHAO, Yuhan JING, Jiayi TANG, Hongshu SUI. Research Progress on Cystic Fibrosis Gene Therapy [J]. Current Biotechnology, 2024, 14(5): 813-819. |
| [7] | Xing JIANG, Chang MENG, Longpan CHEN, Qinglu WANG, Xuewen TIAN. Effects of Hypoxic Exercise on the Expression of Serum Exosome Wnt3a in Obese Rats [J]. Current Biotechnology, 2024, 14(4): 685-693. |
| [8] | Beibei LI, Jianqiang WU. Research Progress of Fas-mediated Non-apoptotic Signaling in Tumor Cells [J]. Current Biotechnology, 2024, 14(3): 406-412. |
| [9] | Hui ZHANG, Bobo LIU, Fengmei LI, Jian CUI. Study on the Involvement of Auxin Signaling Pathway in Response to Powdery Mildew Stress in Pumpkin [J]. Current Biotechnology, 2024, 14(3): 433-441. |
| [10] | Yifan LI, Weiwei FENG, Guanghua MAO, Ting ZHAO, Yao CHEN, Mengna LUO, Xin GENG, Chaoqiong WU, Liuqing YANG, Xiangyang WU. Metabolic Toxicity and Mechanism of Fenitrothion Exposure on BRL Cells [J]. Current Biotechnology, 2024, 14(3): 459-465. |
| [11] | Yan ZENG, Hengcheng ZHU, Kang YANG. The Mechanism of DNASE1L3 in Renal Cell Carcinoma [J]. Current Biotechnology, 2024, 14(3): 486-491. |
| [12] | Weijian ZHAO, Hongting XU, Xiangqian XIAO, Wang SHENG. Research Progress on Hippo Signaling Pathway in Cancer Stem Cell [J]. Current Biotechnology, 2024, 14(2): 211-220. |
| [13] | Yonghong ZHANG, Yanyi LI, Ronglin LIU, Na LYU, Weiting ZHANG. Application of IgY in the Field Antiviral Medical [J]. Current Biotechnology, 2024, 14(1): 35-41. |
| [14] | Lang GAO, Sixue YU, Chunsen YUAN, Zhiwei SHAN, Pengxiang ZHAO. Research Progress of Mucin in Tumor Immunotherapy [J]. Current Biotechnology, 2023, 13(3): 390-398. |
| [15] | Wei ZHANG, Hongfang WANG, Baohua XU. Overview of the Main Molecular Mechanisms of Biological Aging [J]. Current Biotechnology, 2023, 13(2): 228-233. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||